Type III interferon drives thymic B cell activation and regulatory T cell generation

Proc Natl Acad Sci U S A. 2023 Feb 28;120(9):e2220120120. doi: 10.1073/pnas.2220120120. Epub 2023 Feb 21.

Abstract

The activation of thymic B cells is critical for their licensing as antigen presenting cells and resulting ability to mediate T cell central tolerance. The processes leading to licensing are still not fully understood. By comparing thymic B cells to activated Peyer's patch B cells at steady state, we found that thymic B cell activation starts during the neonatal period and is characterized by TCR/CD40-dependent activation, followed by immunoglobulin class switch recombination (CSR) without forming germinal centers. Transcriptional analysis also demonstrated a strong interferon signature, which was not apparent in the periphery. Thymic B cell activation and CSR were primarily dependent on type III IFN signaling, and loss of type III IFN receptor in thymic B cells resulted in reduced thymocyte regulatory T cell (Treg) development. Finally, from TCR deep sequencing, we estimate that licensed B cells induce development of a substantial fraction of the Treg cell repertoire. Together, these findings reveal the importance of steady-state type III IFN in generating licensed thymic B cells that induce T cell tolerance to activated B cells.

Keywords: Treg cell selection; central tolerance; thymic B cells; type III IFN.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Infant, Newborn
  • Interferon Lambda*
  • Receptors, Antigen, T-Cell
  • T-Lymphocytes, Regulatory*
  • Thymocytes
  • Thymus Gland

Substances

  • Interferon Lambda
  • Receptors, Antigen, T-Cell